Prognostic model for disease-free survival, lymphatic and/or hematogenous recurrence, in patients with early stage cervical cancer treated with radical hysterectomy: A Korean Gynecologic Oncology Group Study.

e17000 Background: To develop a model to predict 5 year disease-free survival (DFS), lymphatic and/or hematogenous recurrence, in early stage cervical cancer treated with radical hysterectomy, which can be used to select low-risk patients potentially eligible for less radical surgery. Methods: We retrospective analyzed a multi-institutional cohort of early stage cervical cancer patients treated between 2000 and 2008. According to the order of...